Lv12
40 积分 2025-10-23 加入
Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study
4小时前
已完结
皖公网安备34019202002308
